Jenburkt Pharmaceuticals Limited
JENBURPH.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.17B
Close$
Share Statistics
| Market cap | $4.17 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $20.70 (2.19%) |
| Earnings per Share | $78.71 |
| Beta | 0.36 |
| Outstanding Shares | 4,413,300 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 12.7 |
|---|---|
| PEG | -51.93 |
| Price to Sales | 2.47 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jenburkt Pharmaceuticals Limited
801 employees
CEO: Ashish Uttam Bhuta Jenburkt Pharmaceuticals Ltd. specializes in the creation and commercialization of a wide array of medicinal formulations and healthcare products. Its extensive product range includes treatments for parasitic infestations (anthelmintic),...